University of Miami Miller School of Medicine Conducts Clinical Trials Using Shockwave Therapy to Treat ED
Ranjith Ramasamy, M.D., assistant professor of urology and director of reproductive urology at the University of Miami Miller School of Medicine, has been conducting clinical trials using shockwave therapy treatment to treat ED. A specialist in treating male infertility and sexual dysfunction disorders, Ramasamy’s initial clinical trials show that shockwave therapy has the potential to effectively treat ED through the use of an innovative low-intensity shockwave device that can improve erectile function. This treatment attempts to improve ED by treating its underlying pathophysiology, not just its symptoms.Shockwave therapy is already approved by the Food and Drug Administration (FDA) to promote wound healing in specific areas such as a treating plantar fasciitis, Achilles tendonitis, and epicondylitis of the elbow. The FDA has yet to approve shockwave therapy for ED, and the Miami Miller School of Medicine has been conducting clinical trials using this treatment. Dr. Ramasamy explained that shockwave therapy can increase blood flow to the penis and “recruit” or harvest stem cells that enable men suffering from ED to have better erections. Shockwave therapy for ED differs from Shockwave therapy used on patients with kidney stones in a variety of ways, the most prominent of which is that the energy volume generated is lower and focused on a more concentrated area.
Erectile dysfunction (ED), is a chronic condition that affects 30 million men in the U.S. The best candidates for shockwave therapy treatment are men who have not tried any therapy medications or those who have already tried Viagra or Cialis.
Dr. Ramasamy is a urologist and micro-surgeon, and recently spoke before members of the American Urological Association at its annual convention in San Francisco. His presentation was a summary of randomized clinical trials he conducted on the effects of shockwave therapy for treating ED and his findings regarding the safety and efficacy of this new type of treatment.
Dr. George Ibraheim, DO, Medical Director,
is an Allopathic & Osteopathic Physician with specialties in Interventional Cardiology and Cardiovascular Disease.
John Wolf Jr, MD, Medical Advisor,
has his Training and Certification in Age Management Medicine by the Cenegenics Education and Research Foundation.
Rose Zegarra, PA-C,
with 15 years of experience as a Physician Assistant, including Primary Care medicine, Endocrinology, and Dermatology.
Ian A. Gillman, B.A.,
Clinical Advisor with over 5 years of experience counseling clients on the latest Anti-Aging medical treatments and helping men and women with a variety of sexual and health dysfunctions.